BR112020026602A2 - Radiotraçador de tomografia por emissão de pósitrons (pet) para a imagiologia do receptor do fator estimulante de colônias de macrófagos 1 (csf1r) na neuroinflamação - Google Patents

Radiotraçador de tomografia por emissão de pósitrons (pet) para a imagiologia do receptor do fator estimulante de colônias de macrófagos 1 (csf1r) na neuroinflamação Download PDF

Info

Publication number
BR112020026602A2
BR112020026602A2 BR112020026602-7A BR112020026602A BR112020026602A2 BR 112020026602 A2 BR112020026602 A2 BR 112020026602A2 BR 112020026602 A BR112020026602 A BR 112020026602A BR 112020026602 A2 BR112020026602 A2 BR 112020026602A2
Authority
BR
Brazil
Prior art keywords
group
substituted
alkyl
phenyl
unsubstituted
Prior art date
Application number
BR112020026602-7A
Other languages
English (en)
Portuguese (pt)
Inventor
Andrew G. Horti
Ravi Naik
Robert F. Dannals
Martin G. Pomper
Original Assignee
The Johns Hopkins University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Johns Hopkins University filed Critical The Johns Hopkins University
Publication of BR112020026602A2 publication Critical patent/BR112020026602A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0459—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/002—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nuclear Medicine (AREA)
BR112020026602-7A 2018-06-26 2019-06-26 Radiotraçador de tomografia por emissão de pósitrons (pet) para a imagiologia do receptor do fator estimulante de colônias de macrófagos 1 (csf1r) na neuroinflamação BR112020026602A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862689958P 2018-06-26 2018-06-26
US62/689,958 2018-06-26
PCT/US2019/039234 WO2020006075A1 (en) 2018-06-26 2019-06-26 Positron emission tomography (pet) radiotracers for imaging macrophage colony-stimulating factor 1 receptor (csf1r) in neuroinflammation

Publications (1)

Publication Number Publication Date
BR112020026602A2 true BR112020026602A2 (pt) 2021-03-23

Family

ID=68985080

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112020026602-7A BR112020026602A2 (pt) 2018-06-26 2019-06-26 Radiotraçador de tomografia por emissão de pósitrons (pet) para a imagiologia do receptor do fator estimulante de colônias de macrófagos 1 (csf1r) na neuroinflamação

Country Status (12)

Country Link
US (1) US20210290784A1 (https=)
EP (1) EP3813890A4 (https=)
JP (2) JP2021533087A (https=)
KR (1) KR20210013769A (https=)
CN (2) CN118743770A (https=)
AU (1) AU2019294699B2 (https=)
BR (1) BR112020026602A2 (https=)
CA (1) CA3104520A1 (https=)
EA (1) EA202092843A1 (https=)
IL (1) IL279768B2 (https=)
MX (1) MX2021000141A (https=)
WO (1) WO2020006075A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020132651A1 (en) 2018-12-20 2020-06-25 Amgen Inc. Kif18a inhibitors
EP3898616B1 (en) 2018-12-20 2024-10-02 Amgen Inc. Heteroaryl amides useful as kif18a inhibitors
JP7676308B2 (ja) * 2018-12-20 2025-05-14 アムジエン・インコーポレーテツド Ｋｉｆ１８ａ阻害剤として有用なヘテロアリールアミド
US12540129B2 (en) 2019-08-02 2026-02-03 Amgen Inc. KIF18A inhibitors
WO2021026099A1 (en) 2019-08-02 2021-02-11 Amgen Inc. Kif18a inhibitors
EP4269404A4 (en) * 2020-12-25 2024-12-04 Xizang Haisco Pharmaceutical Co., Ltd. KETOHEXOKINASE INHIBITORS AND USE THEREOF
CA3221884A1 (en) * 2021-06-11 2022-12-15 Norman Lafrance Expert scoring system for measurement of severity, treatment response and prognosis of peripheral arterial disease
AU2024214768A1 (en) * 2023-01-30 2025-08-07 The Johns Hopkins University 18 f-labeled pet radiotracers for imaging macrophage colony stimulating factor 1 receptor
CN118027009B (zh) * 2024-04-15 2024-07-12 北京师范大学 一类靶向于csf1r激酶的苯基酰胺类化合物及其应用
CN119498255B (zh) * 2024-10-24 2025-11-25 香港理工大学深圳研究院 一种抑郁症小鼠模型及其构建方法与应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006047504A1 (en) * 2004-10-22 2006-05-04 Janssen Pharmaceutica, N.V. Aromatic amides as inhibitors of c-fms kinase
CN109069666B (zh) * 2016-04-29 2023-04-04 纪念斯隆凯特琳癌症中心 使靶向颗粒穿透、分布和响应于恶性脑肿瘤中的组合物和方法

Also Published As

Publication number Publication date
WO2020006075A1 (en) 2020-01-02
EP3813890A4 (en) 2022-03-23
MX2021000141A (es) 2021-03-25
KR20210013769A (ko) 2021-02-05
AU2019294699A1 (en) 2021-01-21
CN118743770A (zh) 2024-10-08
IL279768A (en) 2021-03-01
EP3813890A1 (en) 2021-05-05
IL279768B2 (en) 2025-04-01
US20210290784A1 (en) 2021-09-23
AU2019294699B2 (en) 2025-05-01
JP2024133496A (ja) 2024-10-02
EA202092843A1 (ru) 2021-04-19
JP2021533087A (ja) 2021-12-02
CN112638431A (zh) 2021-04-09
CA3104520A1 (en) 2020-01-02
IL279768B1 (en) 2024-12-01

Similar Documents

Publication Publication Date Title
BR112020026602A2 (pt) Radiotraçador de tomografia por emissão de pósitrons (pet) para a imagiologia do receptor do fator estimulante de colônias de macrófagos 1 (csf1r) na neuroinflamação
EP3925952B1 (en) Prostate-specific membrane antigen targeted high-affinity agents for endoradiotherapy of prostate cancer
KR102531494B1 (ko) 탄산 탈수효소 ix를 표적으로 하는 핵 영상화 및 방사선치료 제제 및 이의 용도
HK40117453A (zh) 用於对神经炎症中的巨噬细胞集落刺激因子1受体(csf1r)进行成像的正电子发射断层成像术(pet)放射性示踪剂
JP7590726B2 (ja) 可溶性エポキシドヒドロラーゼ（ｓＥＨ）のＰＥＴイメージング用１８Ｆ－ＦＮＤＰ
WO2024186805A1 (en) Methods of treating cancer
BR122025009780A2 (pt) Compostos, método para tratar uma ou mais células ou tumores que expressam psma in vitro ou ex vivo que utiliza os ditos compostos e uso dos mesmos para tratar tumores ou células que expressam psma
HK1259764B (en) Prostate-specific membrane antigen targeted high-affinity agents for endoradiotherapy of prostate cancer
BR122023014589B1 (pt) Usos de formulação farmacêutica que compreende di-hidrato de monocloridrato de 2-((1-(2-(4-fluorofenil)-2-oxoetil)piperidin-4-il)metil) isoindolin-1-ona

Legal Events

Date Code Title Description
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]